NRX Pharmaceuticals Inc (NRXP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $95.58M
Last updated: Nov 17, 2026 at 4:40 PM ET
NRX Pharmaceuticals Inc (NRXP) Stock Chart
NRX Pharmaceuticals (NRXP) has a latest price of $2.45 on Nov 17, 2026, 51.5% below its 52-week high of $5.05. Its price fell 1.6% over the past 12 months. The month-end price fell 97.7% since Dec 2017, a compound annual decline of 34.6%.
Price Chart
From Dec 2017 to Oct 2026, its highest month-end close was $587.40 in Jan 2021 and its lowest $1.31 in Nov 2024, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart NRXP with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NRXP.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 26.4%, and over 6 months it fell 19.1%. The month-end price fell 30.2% over the 3 years through Oct 2026, a compound annual decline of 11.3%.
| Period | Change |
|---|---|
| 1 month | -6.8% |
| 3 months | -26.4% |
| 6 months | -19.1% |
| 12 months | -1.6% |
| 12 months, with dividends | -1.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -30.2% | -11.3% |
| 5 years | -97.8% | -53.2% |
| Since Dec 2017 | -97.7% | -34.6% |
Price by Year
Its best calendar year was 2020, when the price rose 130.2%, and its weakest was 2021, when it fell 80.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $2.27 | -16.2% |
| 2025 | $2.71 | +23.2% |
| 2024 | $2.20 | -52.2% |
| 2023 | $4.60 | -58.6% |
| 2022 | $11.10 | -76.8% |
| 2021 | $47.80 | -80.4% |
| 2020 | $244.00 | +130.2% |
| 2019 | $106.00 | +3.9% |
| 2018 | $102.00 | +5.4% |
Trading Range
The price is 11.7% below its 50-day average of $2.77 and 17.7% below its 200-day average of $2.98.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $2.45 | |
| 52-week high | $5.05 | -51.5% |
| 52-week low | $1.62 | +51.2% |
| 50-day average | $2.77 | -11.7% |
| 200-day average | $2.98 | -17.7% |
Price Risk
Over 3 years, its largest fall from a peak was 83.4%.
| Measure | Value |
|---|---|
| 1-year beta | 2.16 |
| Largest fall, 1 year | -53.5% |
| Largest fall, 3 years | -83.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About NRXP
What is NRXP's 1-year price change?
NRX Pharmaceuticals's price fell 1.6% over the past 12 months. With dividends included, the 12-month total return was -1.6%.
What is NRXP's 5-year price change?
NRX Pharmaceuticals's month-end price fell 97.8% over the 5 years through Oct 2026, a compound annual decline of 53.2%. These figures leave out dividends.
What is NRXP's 52-week high and low?
NRX Pharmaceuticals's 52-week high is $5.05 and its 52-week low is $1.62. Its latest price of $2.45 on Nov 17, 2026 is 51.5% below the high.
What is NRXP's beta?
NRX Pharmaceuticals's 1-year beta against the S&P 500 is 2.16, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 53.5%.
Is the NRXP chart free?
Yes. Advanced Charting for NRXP is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
NRXP pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors